Publication:


abstract

Current treatment for type 1 diabetes mellitus requires daily insulin injections that fail to produce physiological glycemic control. Islet cell transplantation has been proposed as a permanent cure but is limited by loss of β-cell viability and function. These limitations could potentially be overcome by relying on the activity of glucagon-like peptide 1 (GLP-1), which acts on β-cells to promote insulin release, proliferation and survival. We have developed a peptide amphiphile (PA) molecule incorporating a peptide mimetic for GLP-1. This GLP-1-mimetic PA Self-assembles into one-dimensional nanofibers that stabilize the active secondary structure of GLP-1 and can be cross-linked by calcium ions to form a macroscopic gel capable of cell encapsulation and three-dimensional culture. The GLP-1-mimetic PA nanofibers were found to stimulate insulin secretion from rat insulinoma (RINm5f) cells to a significantly greater extent than the mimetic peptide alone and to a level equivalent to that of the clinically used agonist exendin-4. The activity of the GLP-1-mimetic PA is glucose-dependent, lipid-raft dependent and partially PKA-dependent consistent with native GLP-1. The GLP-1-mimetic PA also completely abrogates inflammatory cytokine-induced cell death to the level of untreated controls. When used as a PA gel to encapsulate RINm5f cells, the GLP-1-mimetic PA stimulates insulin secretion and proliferation in a cytokine-resistant manner that is significantly greater than a non-bioactive PA gel containing exendin-4. Due to its self-assembling property and bioactivity, the GLP-1-mimetic PA can be incorporated into previously developed islet cell transplantation protocols with the potential for significant enhancement of β-cell viability and function.

Copyright © 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Related Articles
Review Glucagon-like peptide-1.
Recent Prog Horm Res. 2001
Review Glucagon-like peptide-1.
Doyle ME, Egan JM. Recent Prog Horm Res. 2001; 56:377-99.
64Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys40-Exendin-4
Molecular Imaging and Contrast...
64Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys40-Exendin-4
Chopra A. Molecular Imaging and Contrast Agent Database (MICAD). 2004
Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Cell Tissue Res. 2002
Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG, Holz GG. Cell Tissue Res. 2002 Feb; 307(2):191-201. Epub 2002 Jan 8.
Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Am J Physiol Endocrinol Metab....
Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M, Jehle DR, Fussgaenger RD, Fehmann HC, Jehle PM. Am J Physiol Endocrinol Metab. 2000 Jul; 279(1):E88-94.
Review beta-cell failure in diabetes and preservation by clinical treatment.
Endocr Rev. 2007
Review beta-cell failure in diabetes and preservation by clinical treatment.
Wajchenberg BL. Endocr Rev. 2007 Apr; 28(2):187-218. Epub 2007 Mar 12.